ID/IQ parent award for pharmacology and toxicology for therapeutics program (pttp). Period of performance: september 30, 2022 - september 12, 2026.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95022D00026
- Awardee
-
University Of Illinois UEI W8XEAJDKMXH3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $526,607 obligated
Award facts
- Opportunity
-
- Pharmacology and Toxicology for Therapeutics Program (PTTP) Pre-Solicitation · 75N95022R00003 · Posted Oct 28, 2021
- Combined order value
-
- $526,607 Current, with exercised options
- $793,245 Potential, with all options
- Last date to order 82% complete
- IDV ceiling <1% used
- $174,470,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Neurological Disorders and Stroke awarded a single-award IDIQ to University Of Illinois with a ceiling of $174,470,000 on September 30, 2022, for the Pharmacology and Toxicology for Therapeutics Program (PTTP).
The contract runs from September 30, 2022, through September 12, 2027. Place of performance is Chicago, Illinois. The IDIQ supports the NIH Blueprint Neurotherapeutics Network's mission to advance therapeutic candidates through pharmacology, toxicology, and safety assessment services. The scope encompasses GLP-compliant and non-GLP toxicology studies in rodents, non-rodents, dogs, rabbits, and non-human primates; acute and chronic toxicity assessment; safety pharmacology; in vitro ADME assays; and lead optimization work across up to 10 non-GLP projects and up to 5 GLP projects annually.
Under this IDIQ, the National Institute on Drug Abuse issued a $270,179 cost-plus-fixed-fee delivery order to University Of Illinois on February 1, 2023, for Performance Area 1 (management and operations support) supporting PTTP implementation, with completion on September 12, 2026. The National Institute of Neurological Disorders and Stroke issued a $523,066 firm-fixed-price delivery order on the same date for non-GLP oral toxicity and toxicokinetic studies of drug molecules in rodents and non-rodents, completing September 30, 2024. Both delivery orders performed in Chicago, Illinois.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Non-GLP, oral toxicity and toxicokinetic studies of drug molecules in rodents and non-rodents | National Institute on Drug Abuse (NIH) | $381,227 | |
| Performance area 1 - management and operations support | National Institute on Drug Abuse (NIH) | $145,380 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Definitize Change Order | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95022D00026?
75N95022D00026 was awarded to University Of Illinois by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2022.
How much is contract 75N95022D00026 worth?
Orders under 75N95022D00026 have obligated $526,607. Their combined potential value, with all options, is $793,245. 75N95022D00026's own ceiling is $174,470,000.
How many orders have been placed under contract 75N95022D00026?
2 orders have been placed under 75N95022D00026, the latest on February 1, 2023.
Which agency awarded contract 75N95022D00026?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022D00026, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract 75N95022D00026?
75N95022D00026 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95022D00026 competed?
The extent of competition for 75N95022D00026 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV